OpenFilings

Phio Pharmaceuticals Corp.

Form10-K

Report Period2024-12-31

Date Filed2025-03-31

Time Filed16:42:20

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

FORM 10-K FOR DEC 2024
FIRST AMENDMENT TO THE EMPLOYMENT AGREEMENT OF ROBERT J. BITTERMAN
INSIDER TRADING POLICY
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
Filing on SEC Edgar